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Abstract : Primary cultures of bovine mammary secretory epithelial cells and spontaneously transformed mammary secretory
epithelial cells were treated with estradiol 17-ß or prolactin separately and in combination with both hormones. Both estradiol
and prolactin induced BRCA1 expression in the cells. Hormone induced expression of BRCA1 was highest in transformed cells.
Moreover, the induction of BRCA1 gene expression was highest when both estrogen and prolactin were in the culture medium.
Gel shift assays showed that STAT5a antibody bound to a 20-bp double stranded oligonucleotide, containing a potential STAT5
response element  (5'-acagtttctaaggaacactg-3',  3'-tgtcaaagattccttgtgac-5'). This is the first report showing that bovine
mammary cells, in culture, are responsive to estrogen and prolactin in inducing expression of bovine BRCA1 and that BRCA1
may contain a STAT5 response element directing expression of the bovine BRCA1 gene. Further work is needed to examine
the presence of estrogen response element(s) in estradiol induced BRCA1 expression. One must determine if PRL induced BRCA1
induction occurs after transfection of STAT5 -/- cells with STAT5a and STAT5a mutant constructs. This will give the strongest
evidence of the direct involvement of a STAT5–BRCA1 signaling pathway.
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Introduction
Prolactin and estrogen influence mammary cell growth and
differentiation (Tucker, 1974). Serum concentrations of these
hormones increase during gestation and prolactin is believed to be
involved in the initiation of stage two lactogenesis (Tucker, 1974).
Both hormones and their receptors have been implicated in breast
cancer and its metastases (Wennbo and Tornell, 2000). The BRCA1
(breast ovarian cancer susceptibility protein) gene encodes a 220
kDa secretory protein with tumor suppressor like properties (Chen
et al., 1996; Miki et al., 1994; Nevalainen et al., 1996). The protein
contains a short sequence shared by granins, proteins in various
types of secretory vesicles whose function(s) is not yet clear
(Jensen et al., 1996). Mutation in the BRCA1 gene is found in
about two-thirds of heritable breast carcinomas and in a n
un-estimated number of ovarian cancers (Futreal et al., 1994).
BRCA1  protein has been localized in both the nucleus and
cytoplasm of cells (Jensen et al., 1996). Its localization appears to
be related t o the type of cell and whether it is normal or o f
neoplastic origin.  We have shown that BRCA1 is differentially
expressed in bovine mammary tissue throughout its development
and involution (Chung and Gorewit, 2001). We have also shown
that the protein is present in milk from lactating cattle, suggesting
that  it can be a secreted protein during lactation (Chung and
Gorewit, 2002). 
It has been recently shown that estrogen and prolactin up-regulate
(BRCA1) expression in human breast cancer cells (Favy et al.,
1999). Although it has been shown that BRCA1 is expressed in
normal and malignant breast tissue, very little is known about the
mechanism(s) whereby prolactin regulates its expression.
STAT  family proteins (Signal Transducers and Activators o f
Transcription) are transcription factors that have been found in
the interferon system (Schindler and Darnell, 1995).  They interact
with gamma interferon via the GAS element (Heim et al., 1995;
Schindler and Darnell, 1995).  At present, eight different STATs
have been molecularly cloned (Heim et al., 1995). STAT proteins
have common features, including SIC and SH3 domains that are
important in protein-protein interactions. 
STAT proteins bind to cytokine receptor via interactions between
phosphorylated tyrosine on the receptor and the SH2 domain of
the STAT (Heim  et al., 1995). STAT binding to receptors i s
activated by JAK (Janus kinase) (Schindler and Darnell, 1995).
Activated  STATs form homodimers or heterodimers and
translocate into the nucleus, where they bind to their specific
target sequences and control gene expression. 
STAT5 was initially identified as mammary gland factor (MGF)
regulated by prolactin (Raught et al., 1994). In the mammary
epithelium, although STATI, STAT3, STAT5A, STAT5B and STAT6
are  present in a latent form, only STAT5A and STAT5B are
activated. This selective activation of STAT5 by prolactin was also
observed in COS-7 cells co-transfected with the long form of the
mouse prolactin receptor (PRL-R) and expression vectors for
STATI, STAT3, STAT5 and STAT6 (Mayr et al., 1998).  
Prolactin receptor (PRLR) is a member of the cytokine/growth
hormone/PRL receptor super family (Goffin  et al., 1999). The
mechanism through which PRLR modulates STAT5 tyrosine
phosphorylation, nuclear translocation, and DNA binding has been
analyzed in HC11 cells, a mammary epithelial cell line, and 293-LA
cells, a human kidney cell line stably over-expressing Jak2 kinase
(Samir and Suhad, 1998). Wartmann et al., 1996 have shown that
in HC11 cells, STAT5 is specifically activated by PRL treatment,
demonstrating that STAT5 is a physiological substrate
downstream of the PRLR.
The pathways connecting extra cellular signals with the regulation
of transcription factor activity are being investigated in detail.
Considerable progress has been made in the description of the
mechanism of action of steroid hormones and cytokines. Steroid
hormones associate intra-cellularly with latent receptor molecules,
cause the dissociation of masking proteins, the dimerization of
receptors, and their binding to specific hormone response
elements in the promoters of target genes (Beato et al., 1996). It
is well known that estrogen up regulates the expression o f
mammary gland prolactin receptors (Cassy et al., 2000; Nevalainen
et al., 1996; Ormandy et al., 1997).
Cytokines also activate latent transcription factors (STATs), but
act through an enzymatic mechanism. For cytokines, tyrosine
kinases associated with the trans-membrane cytokine receptors
phosphorylate STAT molecules (Romagnolo  et al., 1998). The
phosphorylated  monomers dimerize and assume specific DNA
binding ability. Both classes of transcription factors bind t o
different response elements and regulate different target genes
and  both signals, cytokines and steroid hormones, can affect
growth differentiation and homeostasis of different cell types
(Wartmann et al., 1996).
Wyszomierski  et al., 2001 have recently shown that STAT5
functionally interacts with members of the steroid receptor family.
They found that glucocorticoid receptor, mineralocorticoid
receptor and progesterone receptor synergize with STAT5 in the
induction of the transcription from the beta-casein gene promoter.
The estrogen receptor decreased STAT5 mediated induction and
the   androgen   receptor   had   no   effect.  Conversely,  STAT5Chung and Gorewit:  BRCA1 gene expression 
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negatively interfered with glucocorticoid receptor. The estrogen 10 mM NaCL) by heating at lOO °C for 5 min and cooling to room
receptor  induced transcription from an estrogen response temperature. Annealed oligonucleotide pairs were 3' end labeled
element-containing promoter.  with biotin-dATP by terminal transferase (Life Technologies, Inc.).
The objectives of the work described in this report were t o Ten nanograms of nuclear extracts were pre-incubated for 10 min
determine if estrogen and prolactin could increase expression of in a buffer containing 20 mM HEPES, pH 7.9,50 mM NaCl, I mM
BRCA1 in bovine mammary cells and explore the potential role of MgCl , I mM dithiothretol, I mM EDTA, I ng of poly (dA-dT)-poly
STAT5 in the process.  (dA-dT), and 10 % glycerol. Probes (15 ftnol) were then added and
Materials and Methods
Cell Culture: Bovine primary mammary epithelial cells were
obtained as described by (Zavizion  et al., 1992). Cells were
cultured in medium containing a 1:1 (v/v) mixture of RPMI-1640
and Dulbecco's Modified Eagle Medium (Life Technologies, Inc)
supplemented with 12% fetal bovine serum, penicillin (100 IU/ml),
and streptomycin (100 ng/ml) at 37 C in 5 % C0 . Media were 2
changed everyday the first week. After that, media were changed
2 to 3 times/week. Cells were passed before confluence using a
0.05 % trypsin solution (Life Technologies, Inc.) to maintain
experimental cultures. A bovine mammary epithelial cell line (BME)
was also cultured under the same culture conditions as primary
epithelial cell (Zavizion et al., 1992).
Effects of estrogen and prolactin on BRCA1 induction: In order to mammary epithelial cell line (BME) was more responsive to E2 and
determine the effect of estrogen and prolactin on induction of PRL, within an hour of incubation, than primary epithelial cells
BRCAl expression, primary cultures of bovine mammary epithelial (Fig.1) for BRCA1 gene induction. Estradiol 17-ß and PRL induced
cells and BME cell line cultures were treated with estradiol 17-ß or significant increases in BRCA1 expression in BME cells. The
prolactin or a combination of estradiol 17-ß and prolactin and combination of these two hormones showed an additive effect,
assayed for BRCA1 expression by RNAse protection assay (RPA). which was two times the increase compared to BRCA1 gene
Cells (2 x 10 ) were plated in 100 mm dishes and left to grow to induction seen in the control (Fig.1). 6
confluency. Before hormone treatment, cells were serum starved Marquis et al., 1995; Gudas et al., 1995  reported up-regulation of
for 24h and media were changed without serum twice. Cells were BRCA1 by ovarian hormones, 17B-estradiol and progesterone (P)
then treated with E2 (0.5 ng/ml) or PRL (200 ng/ml) or  a in ovariectomized mice and in breast cancer cells. More recently,
combination of E2 and PRL (.5ng/ml E2 and 200 ng/ml PRL). After Favy et al., 1999  reported prolactin (PRL)-dependent up-regulation
1 hour, medium was discarded and cells were lysed by Tri reagent of BRCA1 expression in human breast cancer cells. However,
LS (Molecular Research Center) to isolate total RNA using the molecular mechanisms explaining how E2, and PRL up regulate
manufacture's recommendation on assay procedures. BRCA1 are unknown. 
Ribonuclease Protection Assay (RPA): Total BRCA1 transcript levels hormones 18 or 24 h before analysis of BRCA1 mRNA expression.
were measured using a ribonuclease protection assay and  a However, our cells were incubated for only one hour with these
Multi-NPA hybridization procedure (Ambion, Inc.). The template to hormones. The BME cells showed high sensitivity within an hour
generate a ribo-probe was prepared by PCR from bovine BRCA1 to E2 and PRL for BRCA1 gene induction. The E2 and PRL
cDNA.  BRCA1 primer pair, forward (+85/+104): combination induced additive BRCA1 mRNA expression. In BME
5'tctgctctgggtaagttca  3' and backward (+640/+620): cells, BRCA1 responded to mammotropic hormones like an early
5'atttaggtgacactatagaatgatgttgtatccgctgctt 3' was used for response gene. The primary epithelial cells did not show the same
preparation of template. The reverse primer contained the SP6 degree of response.
RNA polymerase-binding site to make antisense ribo-probe. This result posed two questions. Why was the response different
A 500 nt biotin labeled antisense ribo-probe was synthesized by in these two different cells and do these hormones directly effect
MAXI Script (Ambion) according to the manufacturer's BRCA1 gene induction?  To answer the first question, let u s
recommendations. The synthesized probe was gel purified and consider primary characteristics of these two cells. BME cells are
hybridized with 15 :g of total RNA to protect a fragment of the spontaneously mutated cells. We believe this cell line is much more
expected length. After nuclease digestion, the protected fragment proliferative than primary epithelial cells in response to E2 and PRL.
was  electrophoresed and transferred to nylon membrane b y This characteristic may have resulted in the difference of BRCA1
electro-transfer. Protected fragments were detected by Ambion's induction seen, even though its response was within an hour.
Bright star biodetection kit. BRCA1 mRNA was quantified by Photo Therefore, we speculate that protective feedback mechanisms of
Image IS 1000 with arbitrary units corrected for the expression of cells induce the growth regulator, BRCA1.
the control, actin mRNA (BRCA1/Actin).
Gel shift assays: Bovine mammary epithelial cell line (BME) was because t he BME cells were more responsive to E2 and PRL
cultured until confluency, serum starved for 24h and media were individually, than primary epithelial cells. We used oligo nucleotides
changed without serum twice. The cells were then treated with of potential  STAT5 response elements for the assay. A potential
estrogen (0.2, 0.8 ng/ml) or prolactin (100, 200 ng/ml) or  a GAS/STAT5 binding element was incubated with nuclear extract
combination of estrogen (0.2 ng/ml) and prolactin (100 ng/ml) for and resulted in bands on membrane (Fig. 2). Hormone treated cells
1 hour. BME Nuclear extracts were prepared according to the showed more intense bands than untreated control cells.
method  of Lemkin  et al., 2000. A 20-bp double stranded Moreover, the band intensity was sensitive to PRL concentration
oligonucleotide,  containing potential STAT5 response element, (Fig. 2).  Super-shift assays showed reactions of STAT5a antibody
(5'-acagtttctaaggaacactg-3', 3'-tgtcaaagattccttgtgac-5') was with BRCA1.  Shifted bands were seen compared to controls
synthesized based on the human BRCA1 promoter sequence (NID: without STAT5a antibody (Fig. 2).
gl 147602). Oligonucleotide was purified by polyacrylamide gel The best-known functions of PRL in the mammary gland are its
electrophoresis, and equimolar quantities of complementary ability to induce lobuloalveolar growth (Wennbo and Tornell, 2000)
strands were annealed in buffer (10 mM Tris, pH 8.0, ImM EDTA, and to stimulate postpartum lactogenesis (Wennbo and  Tornell,
2
the incubation continued at room temperature for 15 min.
In experiments to identify the protein component of the
protein-DNA complexes (super shift assay), antibodies raised
against STAT5a, were purchased from Santa Cruz Biotechnology
(CA). Antibodies were incubated with the nuclear extracts for 15
min at room temperature before addition of the probe.
Protein-DNA complexes were separated on a 5% nondenaturing
polyacrylamide gel (38:1, Acrylamide-bisacrylamide; 2 % glycerol;
22 mM Tris-borate, 0.5 mM EDTA, pH 8.3) at 15 mA (l h at 4 °C).
Gels were transferred onto nylon membrane and cross linked and
DNA-protein  antibody complexes were detected by Ambion's
CDP-star biotin detection kit.
Results and Discussion
Effects of erstrogen and prolactin on BRCA1 induction: The bovine
In previous studies, breast cancer cells were incubated with
Gel shift assays : We selected BME cells for the gel shift assayChung and Gorewit:  BRCA1 gene expression 
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A) BME Potential Gas
B)
C)
D)
Fig. 1: BRCA1 gene expression in cultured bovine mammary
epithelial cells. An RNAse protection assay was performed
for bovine BRCA1 gene induction within 1 h of incubation
with E2 (0.5 ng/ml) or PRL (200 ng/ml) or a combination of
E2 and PRL (.5ng/ml E2 and 200 ng/ml PRL) in BME cells
(A) and primary cultured bovine mammary epithelial cells
(C) using biotin anti-sense probes of BRCA1 and ß-actin.
(B) and (D) quantification of BRCA1 mRNA expression is
shown in (A) and (C), respectively. Relative BRCA1 mRNA
expression to ß-actin mRNA expression is also shown.
Experiments were done in triplicate and means and
standard  errors of the means are shown as bars o n
graphs. The radiographs are examples of the replicates.
2000) . These properties are mediated through the activation of
genes involved in many growth control and differentiation. STAT5
knockout mice show poor mammary gland development (Lemkin
et al., 2000).  Further, Yang et al., 2000 recently showed that
STAT5 is differentially expressed throughout various stages of
lactation in cows, thus suggesting that the STAT system i s
involved in the regulation of mammary gland growth and
differentiation.  The expression of STAT5 was identical to the
expression patterns that were found for bovine mammary gland
BRCA1 (Chung and Gorewit, 2001).
In our experiments, the potential GAS (-177/-160) element showed
a shifted band with STAT5a antibody.   Therefore,   there   is   a
1      2     3     4     5     6                       7    8    9   10   11   12
Fig. 2: Identification of a GAS(-290/-309) oligonucleotide in the
BRCA1 promoter. The potential GAS biotin labeled
oligonucleotide was incubated with nuclear extract.
Nuclear extracts from control cells (lane 1), nuclear
extracts from cells treated with 100 ng/ml PRL (lane 2) and
10 ng/ml PRL (lane 3). Lane 4 represents extracts treated
with 0.2ng/ml E2. Lanes 5 and 6 represent extracts
treated with a combination of 100 ng/ml PRL + 0.2 ng/ml
of E 2. Lanes 7-12 represent extracts incubated with
STAT5a antibody alone. Experiments were done i n
triplicate  and the radiograph is an example of the
replicates.
possibility that the PRL-STAT5 pathway may be a direct BRCA1
regulator. To confirm a PRL-STAT5-BRCA1 pathway, it i s
necessary to perform further studies. One must determine if PRL
induced BRCA1 induction occurs after transfection of STAT5 -/-
cells with STAT5 and STAT5 mutant constructs. This will give the
strongest evidence of the direct involvement of a STAT5 -BRCA1-
signaling pathway.  Further work is needed to determine if the
estrogen receptor response element is involved in the estrogen
induced up regulation of BRCA1 in bovine mammary cells.
Estrogen and prolactin enhance expression of the bovine BRCA1
gene in cultured bovine mammary secretory epithelial cells. The
combination of estrogen and prolactin enhance BRAC1 above that
seen for either hormone given alone. Antibody to STAT5a binds to
an element that binds to the BRCA1 gene suggesting that a STAT
5 signaling system may be involved in BRCA1 gene expression in
bovine mammary epithelial cells.
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